Levels of brain‐derived neurotrophic factor in patients with multiple sclerosis

Levels of brain‐derived neurotrophic factor in patients with multiple sclerosis

Abstract Objective To determine the levels of brain‐derived neurotrophic factor (BDNF) in the serum of patients suffering from multiple sclerosis (MS) to evaluate the potential of serum BDNF as a biomarker for MS. Methods Using a recently validated enzyme‐linked immunoassay (ELISA) we measured BDNF...

Full description

Bibliographic Details
Main Authors: Yvonne Naegelin, Katharina Saeuberli, Sabine Schaedelin, Hayley Dingsdale, Stefano Magon, Sergio Baranzini, Michael Amann, Katrin Parmar, Charidimos Tsagkas, Pasquale Calabrese, Iris Katharina Penner, Ludwig Kappos, Yves‐Alain Barde
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51215

Internet

https://doi.org/10.1002/acn3.51215

Similar Items